Deslanoside

CAS No. 17598-65-1

Deslanoside( Deacetyllanatoside C | Desacetyllanatoside C )

Catalog No. M21488 CAS No. 17598-65-1

Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 155 Get Quote
10MG 260 Get Quote
25MG 440 Get Quote
50MG 617 Get Quote
100MG 872 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Deslanoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
  • Description
    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Deacetyllanatoside C | Desacetyllanatoside C
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    Na+/K+-ATPase
  • Research Area
    Cardiovascular Disease
  • Indication
    Congestive cardiac insufficiency arrhythmias and heart failure.

Chemical Information

  • CAS Number
    17598-65-1
  • Formula Weight
    943.1
  • Molecular Formula
    C47H74O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (106.04 mM)
  • SMILES
    C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O
  • Chemical Name
    4-((3S5R8R9S10S12R13S14S17R)-1214-dihydroxy-3-(((2R4S5S6R)-4-hydroxy-5-(((2S4S5S6R)-4-hydroxy-5-(((2S4S5S6R)-4-hydroxy-6-methyl-5-(((2S3R4S5S6R)-345-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1013-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hauptman PJ et al. Digitalis. Circulation. 1999 Mar 9;99(9):1265-70.
molnova catalog
related products
  • NDI-091143

    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.

  • BHQ

    BHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.

  • Bufalin

    Bufalin is an active ingredient and one of the glycosides in the traditional Chinese medicine ChanSu.